Last $83.49 USD
Change Today -0.21 / -0.25%
Volume 365.0K
CVD On Other Exchanges
Symbol
Exchange
New York
Stuttgart
As of 6:40 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard F. Cimino

Executive Vice President and Group President of Clinical Development Services, Covance Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

54$1,769,472
As of Fiscal Year 2013

Background*

Mr. Richard F. Cimino, also known as Rick, has been Executive Vice President and the Group President of Clinical Development at Covance Inc. since November 2010. Mr. Cimino served as Corporate Senior Vice President and President of Clinical Development at Covance Inc. from December 2004 to November 2010 and served as its President of Late Stage Development Services. Mr. Cimino is responsible for the global Clinical Development, Periapproval, IVRS and Central Diagnostics ...

Read Full Background

Corporate Headquarters*

210 Carnegie Center
Princeton, New Jersey 08540

United States

Phone: 609-452-4440
Fax: 609-452-9375

Board Members Memberships*

2005-2011
Former Independent Director

Education*

Bachelor's Degree
State University of New York at Geneseo

Other Affiliations*

Annual Compensation*

Salary$420,500
Bonus$500
Total Annual Compensation$421,000

Stock Options*

Restricted Stock Awards$345,050
All Other Compensation$11,625
Exercised Options6,000
Exercised Options Value$270,337
Exercisable Options45,333
Exercisable Options Value$1,362,138
Unexercisable Options23,350
Unexercisable Options Value$646,880
Total Value of Options$2,279,354
Total Number of Options74,683

Total Compensation*

Total Annual Cash Compensation$871,325
Total Short Term Compensation$421,000
Other Long Term Compensation$356,675
Total Calculated Compensation$1,769,472
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CVD:US $83.49 USD -0.21

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Josef H. von Rickenbach Founder, Chairman and Chief Executive Officer
PAREXEL International Corporation
$841.7K
Walter M. Rosebrough Jr.Chief Executive Officer, President, Director and Member of Compliance Committee
Steris Corp.
$788.5K
James C. Foster J.D.Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Strategic Planning & Capital Allocation Committee
Charles River Laboratories International, Inc.
$1.1M
Donald E. Morel Jr., Ph.D.Chairman and Chief Executive Officer
West Pharmaceutical Services, Inc.
$825.0K
John R. Chiminski Chief Executive Officer, President and Director
Catalent, Inc.
$850.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COVANCE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.